Skip to main content

Table 3 Association between PAX6 methylation and clinicopathological characteristics of 160 HCC patients

From: Quantitative methylation analysis reveals distinct association between PAX6 methylation and clinical characteristics with different viral infections in hepatocellular carcinoma

Etiology

All

HBV

HCV

NBC

OR

95 % CI

OR

95 % CI

OR

95 % CI

OR

95 % CI

Age

1.04

1.01–1.07

1.03

0.98–1.08

1.02

0.96–1.07

1.02

0.96–1.07

Gender

1.14

0.60–2.16

1.68

0.51–5.48

1.07

0.38–3.00

1.56

0.31–7.87

HBV

0.29

0.15–0.58

      

HCV

4.46

2.26–8.80

      

Cirrhosis

1.42

0.75–2.69

0.92

0.30–2.78

0.85

0.29–2.50

12.00

1.11–129.42

Tumor size (cm)

0.97

0.90–1.04

0.99

0.89–1.09

0.96

0.81–1.14

1.06

0.89–1.26

Nodules

1.01

0.84–1.20

0.97

0.74–1.27

1.02

0.33–3.11

1.49

0.91–2.44

TNM

1.02

0.72–1.43

1.36

0.74–2.50

0.89

0.48–1.65

1.68

0.75–3.78

AFP

1.24

0.61–2.51

1.17

0.32–4.25

1.46

0.46–4.65

1.00

0.21–4.71

Invasion

1.01

0.56–1.89

2.92

0.90–9.51

0.41

0.14–1.18

2.85

0.57–14.33

  1. OR odds ratio, 95 % CI 95 % confidence interval for the hazard ratio